PMID- 35941689 OWN - NLM STAT- MEDLINE DCOM- 20220810 LR - 20220816 IS - 1756-6606 (Electronic) IS - 1756-6606 (Linking) VI - 15 IP - 1 DP - 2022 Aug 8 TI - The tyrosine capsid mutations on retrograde adeno-associated virus accelerates gene transduction efficiency. PG - 70 LID - 10.1186/s13041-022-00957-0 [doi] LID - 70 AB - Adeno-associated virus (AAV) vector is a critical tool for gene delivery through its durable transgene expression and safety profile. Among many serotypes, AAV2-retro is typically utilized for dissecting neural circuits with its retrograde functionality. However, this vector requires a relatively long-term incubation period (over 2 weeks) to obtain enough gene expression levels presumably due to low efficiency in gene transduction. Here, we aimed to enhance transgene expression efficiency of AAV2-retro vectors by substituting multiple tyrosine residues with phenylalanines (YF mutations) in the virus capsid, which is previously reported to improve the transduction efficiency of AAV2-infected cells by evading host cell responses. We found that AAV2-retro with YF mutations (AAV2-retroYF)-mediated transgene expression was significantly enhanced in the primary culture of murine cortical neurons at 1 week after application, comparable to that of the conventional AAV2-retro at 2 week after application. Moreover, transgene expressions in the retrogradely labeled neurons mediated by AAV2-retroYF were significantly increased both in the cortico-cortical circuits and in the subcortical circuits in vivo, while the retrograde functionality of AAV2-retroYF was equally effective as that of AAV2-retro. Our data indicate that YF mutations boost AAV2-retro-mediated retrograde gene transduction in vivo and suggest that the AAV2-retroYF should be useful for efficient targeting of the projection-defined neurons, which is suited to applications for dissecting neural circuits during development as well as future clinical applications. CI - (c) 2022. The Author(s). FAU - Nakahama, Ryota AU - Nakahama R AD - Department of Biological Sciences, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. FAU - Saito, Aika AU - Saito A AD - Department of Biological Sciences, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. FAU - Nobe, Sensho AU - Nobe S AD - Department of Biological Sciences, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. FAU - Togashi, Kazuya AU - Togashi K AD - Department of Biological Sciences, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. FAU - Suzuki, Ikuo K AU - Suzuki IK AD - Department of Biological Sciences, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. FAU - Uematsu, Akira AU - Uematsu A AD - Department of Biological Sciences, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. akirauematsu0104@gmail.com. AD - International Research Center for Neurointelligence (WPI-IRCN), The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. akirauematsu0104@gmail.com. FAU - Emoto, Kazuo AU - Emoto K AD - Department of Biological Sciences, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. emoto@bs.s.u-tokyo.ac.jp. AD - International Research Center for Neurointelligence (WPI-IRCN), The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. emoto@bs.s.u-tokyo.ac.jp. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220808 PL - England TA - Mol Brain JT - Molecular brain JID - 101468876 RN - 42HK56048U (Tyrosine) SB - IM MH - Animals MH - *Capsid MH - *Dependovirus/genetics MH - Genetic Vectors MH - Mice MH - Mutation/genetics MH - Transduction, Genetic MH - Tyrosine/genetics PMC - PMC9358834 OTO - NOTNLM OT - Adeno-associated virus OT - Cortex OT - Limbic area OT - Monosynaptic anterograde transport OT - Retrograde transport COIS- The authors declare that they have no competing interests. EDAT- 2022/08/09 06:00 MHDA- 2022/08/11 06:00 PMCR- 2022/08/08 CRDT- 2022/08/08 23:53 PHST- 2022/05/21 00:00 [received] PHST- 2022/07/28 00:00 [accepted] PHST- 2022/08/08 23:53 [entrez] PHST- 2022/08/09 06:00 [pubmed] PHST- 2022/08/11 06:00 [medline] PHST- 2022/08/08 00:00 [pmc-release] AID - 10.1186/s13041-022-00957-0 [pii] AID - 957 [pii] AID - 10.1186/s13041-022-00957-0 [doi] PST - epublish SO - Mol Brain. 2022 Aug 8;15(1):70. doi: 10.1186/s13041-022-00957-0.